Sawyer & Company, Inc Abb Vie Inc. Transaction History

Sawyer & Company, Inc

$270 Million
Q3 2024

A detailed history of Sawyer & Company, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Sawyer & Company, Inc holds 16,421 shares of ABBV stock, worth $2.91 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares

16,421

Previous 17,013 3.48%

Holding current value

$2.91 Million

Previous $2.92 Million 11.14%

% of portfolio

1.2%

Previous 1.16%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$163.84 - $199.33 $96,993 - $118,003	-592 Reduced 3.48%	16,421 $3.24 Million
Q2 2024 Jul 31, 2024	SELL	$154.79 - $180.76 $18,574 - $21,691	-120 Reduced 0.7%	17,013 $2.92 Million
Q1 2024 Apr 16, 2024	SELL	$159.82 - $182.1 $51,142 - $58,272	-320 Reduced 1.83%	17,133 $3.12 Million
Q4 2023 Jan 17, 2024	SELL	$137.6 - $154.97 $128,105 - $144,277	-931 Reduced 5.06%	17,453 $2.71 Million
Q3 2023 Oct 25, 2023	BUY	$133.59 - $154.65 $13,359 - $15,465	100 Added 0.55%	18,384 $2.74 Million
Q1 2023 Apr 19, 2023	SELL	$144.61 - $166.54 $143,453 - $165,207	-992 Reduced 5.15%	18,284 $2.95 Million
Q4 2022 Jan 11, 2023	SELL	$138.31 - $165.87 $5,532 - $6,634	-40 Reduced 0.21%	19,276 $3.12 Million
Q3 2022 Oct 25, 2022	SELL	$134.21 - $153.93 $33,552 - $38,482	-250 Reduced 1.28%	19,316 $2.59 Million
Q2 2022 Jul 20, 2022	SELL	$137.62 - $174.96 $179,181 - $227,797	-1,302 Reduced 6.24%	19,566 $3 Million
Q1 2022 Apr 26, 2022	SELL	$131.98 - $163.75 $4,619 - $5,731	-35 Reduced 0.17%	20,868 $3.38 Million
Q4 2021 Jan 14, 2022	SELL	$107.43 - $135.93 $11,387 - $14,408	-106 Reduced 0.5%	20,903 $2.83 Million
Q3 2021 Nov 03, 2021	BUY	$106.4 - $120.78 $34,048 - $38,649	320 Added 1.55%	21,009 $2.27 Million
Q2 2021 Jul 29, 2021	BUY	$105.21 - $117.21 $33,141 - $36,921	315 Added 1.55%	20,689 $2.33 Million
Q4 2020 Jan 26, 2021	SELL	$80.49 - $108.67 $6,841 - $9,236	-85 Reduced 0.42%	20,374 $2.18 Million
Q3 2020 Oct 20, 2020	SELL	$85.91 - $100.83 $13,401 - $15,729	-156 Reduced 0.76%	20,459 $1.79 Million
Q2 2020 Jul 31, 2020	SELL	$73.37 - $98.18 $6,603 - $8,836	-90 Reduced 0.43%	20,615 $2.02 Million
Q1 2020 May 06, 2020	SELL	$64.5 - $97.79 $23,865 - $36,182	-370 Reduced 1.76%	20,705 $1.58 Million
Q4 2019 Jan 13, 2020	BUY	$72.13 - $90.25 $8,294 - $10,378	115 Added 0.55%	21,075 $1.87 Million
Q3 2019 Oct 17, 2019	SELL	$62.98 - $75.72 $52,903 - $63,604	-840 Reduced 3.85%	20,960 $1.59 Million
Q2 2019 Jul 23, 2019	SELL	$65.7 - $83.98 $37,777 - $48,288	-575 Reduced 2.57%	21,800 $1.59 Million
Q1 2019 May 06, 2019	SELL	$77.14 - $90.79 $1.7 Million - $2 Million	-22,000 Closed	0 $0
Q4 2018 Jan 25, 2019	SELL	$77.85 - $96.01 $63,447 - $78,248	-815 Reduced 3.57%	22,000 $2.03 Million
Q3 2018 Oct 22, 2018	BUY	$88.91 - $98.84 $160,482 - $178,406	1,805 Added 8.59%	22,815 $2.16 Million
Q2 2018 Jul 18, 2018	BUY	$89.78 - $106.23 $44,890 - $53,115	500 Added 2.44%	21,010 $1.95 Million
Q4 2017 Jan 11, 2018	BUY	$89.56 - $98.21 $1.84 Million - $2.01 Million	20,510	20,510 $1.98 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawyer & Company, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sawyer & Company, Inc with notifications on news.

Account

Sawyer & Company, Inc Abb Vie Inc. Transaction History